Boston Scientific has announced it has received FDA approval its INGENIO and ADVANTIO pacemakers and INVIVE cardiac resynchronization therapy pacemakers, according to a news release. The INGENIO and ...
Oct 22 (Reuters) - Boston Scientific (BSX.N), opens new tab raised its annual profit forecast on Wednesday, after beating third-quarter profit estimates on strong demand for its heart devices, sending ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results